Galactan induces macrophage M0 to M1 conversion to combat colon cancer

被引：2
|
作者：
Meng, Yue [1 ]
Yang, Guang [1 ]
Ren, Ai [1 ]
Qu, Yunhe [1 ]
Wang, Xue [1 ]
Mayo, Kevin H. [2 ]
Zhou, Yifa [1 ]
Song, Chengcheng [1 ]
机构：
[1] Northeast Normal Univ, Engn Res Ctr Glycoconjugates, Sch Life Sci,Minist Educ, Jilin Prov Key Lab Chem & Biol Changbai Mt Nat Dru, Changchun 130024, Peoples R China
[2] Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA
来源：
FOOD SCIENCE AND TECHNOLOGY RESEARCH | 2024年 / 30卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cantharellus cibarius; galactan; macrophages; antitumor effect; TUMOR-ASSOCIATED MACROPHAGES; STRUCTURAL-CHARACTERIZATION; IMMUNOMODULATORY ACTIVITY; CELLS; ACTIVATION; MECHANISMS; PHENOTYPE;
D O I：
10.3136/fstr.FSTR-D-23-00039
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
A 3-O-methylated-galactan WCCP-N-b from Cantharellus cibarius polarizes RAW264.7 macrophages, bone marrow -derived macrophages (BMDMs), and peritoneal macrophages (PEMs) leading to enhanced secretion of cytokine TNF-alpha and subsequent cytotoxic effects on HCT116 and CT26 colon cancer cells. Investigation into the mechanism of action suggests that WCCP-N-b polarizes macrophages by targeting Toll -like receptor 2 and activation of MAPKs and NF -KB signaling pathways. Overall, our results indicate that this linear 3-O-methylated-galactan inhibits colon cancer cells via conversion of M0 to M1 macrophages.
引用
收藏
页码：75 / 82
页数：9
相关论文
共 50 条
  • [1] SUPPRESSION OF ANGIOGENIC ACTIVITY IN MACROPHAGE (M0) HYBRIDS BY NONACTIVATED AND UNDIFFERENTIATED M0
    POLVERINI, PJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 44 - 44
  • [2] The role of natural exosomes from SHED-MSC in immunoregulation of M0/M1 polarized macrophage cells
    Fallah, Ali
    Colagar, Abasalt Hosseinzadeh
    Khosravi, Ayyoob
    Mohammad-Hasani, Azadeh
    Saeidi, Mohsen
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] 货币供应量及M0、M1、M2
    启龙
    中国核工业, 1999, (02) : 36 - 36
  • [4] In Vivo Delivery of M0, M1, and M2 Macrophage Subtypes via Genipin-Cross-Linked Collagen Biotextile
    Isali, Ilaha
    McClellan, Phillip
    Wong, Thomas R.
    Cingireddi, Snigdha
    Jain, Mukesh
    Anderson, James M.
    Hijaz, Adonis
    Akkus, Ozan
    TISSUE ENGINEERING PART A, 2022, 28 (15-16) : 672 - 684
  • [5] LHC constraints on M1/2 and m0 in the semi-constrained NMSSM
    Debottam Das
    Ulrich Ellwanger
    Ana M. Teixeira
    Journal of High Energy Physics, 2013
  • [6] 市场货币供应量:M0、M1和M2
    曾俊林
    四川省情, 2008, (04) : 25 - 25
  • [7] Health services utilization differences between patients with metastatic (M1) and nonmetastatic (M0) prostate cancer (PCa)
    Yong, Candice
    Onukwugha, Ebere
    Mullins, C. Daniel
    Seal, Brian S.
    Hussain, Arif
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [8] LYMPHOKINE DEPENDENT MACROPHAGE (M0) ACTIVATION IN NEWBORNS
    WILSON, CB
    WESTALL, J
    PEDIATRIC RESEARCH, 1985, 19 (04) : A284 - A284
  • [9] 一文读懂M0、M1、M2:货币世界的密码
    弘观
    现代商业银行, 2025, (06) : 80 - 81
  • [10] DIFFERENCES IN PROVIDER ENCOUNTERS BETWEEN METASTATIC (M1) AND NON-METASTATIC (M0) PROSTATE CANCER (PCA) PATIENTS
    Yong, Candice
    Onukwugha, Eberechukwu
    Mullins, C. Daniel
    Seal, Brian
    Hussain, Arif
    JOURNAL OF UROLOGY, 2013, 189 (04): : E321 - E322
12345